Global Biopharmaceutical Process Analytical Technology Market
Dublin, July 01, 2024 (GLOBE NEWSWIRE) — The “Global Biopharmaceutical Process Analytical Technologies Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analytical Instruments, Sensors, Software), Application (Vaccines, Biologics, CGT), End User – Forecast to 2029” report has been added. ResearchAndMarkets.com Recruitment.
The global biopharmaceutical process analytical technologies market is expected to grow from USD 1.2 billion in 2024 to USD 2.6 billion in 2029, at a CAGR of 16.0% during the forecast period (2024-2029).
The market is on an upward trend owing to increasing R&D activities in biopharmaceuticals and advancements in technology to improve process efficiency. However, obstacles such as shortage of skilled manpower and high cost of implementing process analytical technology (PAT) are hindering the market growth.
Key players in the biopharmaceutical process analytical technology market include Thermo Fisher Scientific (US), Danaher Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Waters Corporation (US), Bruker Corporation (US), Emerson Electric Company (US), ABB (Switzerland), PerkinElmer (US), Mettler Toledo International (US), and Carl Zeiss (Germany).
The liquid chromatography/HPLC segment will account for the largest market share in 2023.
Based on type, the global biopharmaceutical process analytical technologies market has been categorized into five major segments: liquid chromatography, gas chromatography, mass spectrometry, real-time PCR/QPCR, NGS, NMR spectroscopy, Raman spectroscopy, infrared spectroscopy, particle counters and imaging, differential photoelectron scattering, and other technologies. By technology, liquid chromatography/HPLC will account for the major market share in 2023. The increasing adoption of liquid chromatography/HPLC technologies to assess the quality of biopharmaceuticals is a key driver for the rapid expansion of this sector.
The software segment is projected to register the highest CAGR during the forecast period.
Biopharmaceutical Process Analytical Technology (PAT) services are offered to enhance the implementation of Quality by Design (QbD) frameworks. These services include various software solutions such as PAT implementation consulting, software development, regulatory compliance, and process control. The software sector is expected to witness significant growth due to the increasing demand for services that are essential for creating PAT models and executing PAT strategies in biopharmaceutical manufacturing.
Based on application, the vaccines segment accounted for the largest market share in 2023.
Based on application, the biopharmaceutical process analytical technologies market is broadly categorized into vaccines, cell and gene therapy, biosimilars and biologics, hormone therapy, and other applications. The vaccines segment accounted for the largest share of the market in 2023. Stringent regulations on drug development and safety are the main drivers of expansion in this sector, enhancing the efficiency and effectiveness of biopharmaceutical manufacturing. Moreover, increased efforts in biopharmaceutical research and expansion of production to meet the growing demand for drugs are contributing significantly to this growth.
The market in the APAC region is expected to witness the highest growth during the forecast period.
China, India and Japan are the major markets in the Asia Pacific region. The growth of the Asia Pacific market is driven by strategic expansion by key market players in emerging Asian countries, a thriving Contract Research and Manufacturing (CRAM) industry in India, South Korea, Singapore and China, a significant presence of the biopharmaceutical industry in Singapore, and hosting of conferences, exhibitions and meetups focusing on analytical instrumentation.
This report provides insights into:
-
Market Penetration: Comprehensive information on product portfolios offered by leading companies in the biopharmaceutical process analytical technologies market
-
Product Development/Innovation: Detailed insights into upcoming trends, R&D activities, and product launches in the biopharmaceutical process analytical technologies market.
-
Market development: Comprehensive information on lucrative emerging regions
-
Market Diversification: Comprehensive information on new products, growing regions, and recent developments in the biopharmaceutical process analytical technologies market.
-
Competitive Assessment: A detailed assessment of market segments, growth strategies, revenue analysis, and products of the key market players.
Key attributes:
|
Report Attributes |
detail |
|
number of pages |
248 |
|
Forecast Period |
2024 – 2029 |
|
Estimated market value in 2024 (USD) |
$1.2 billion |
|
Market value forecast to 2029 (USD) |
$2.6 billion |
|
Compound Annual Growth Rate |
16.0% |
|
Target area |
global |
Company Profile
-
Waters Corporation
-
Danaher Corporation
-
Thermo Fisher Scientific Inc.
-
Agilent Technologies Japan
-
Shimadzu Corporation
-
PerkinElmer Co., Ltd.
-
Bruker Corporation
-
Mettler Toledo International Inc.
-
Carl Zeiss AG (Zeiss Group)
-
Emerson Electric Company
-
ABB
-
Sartorius AG
-
Process Insights, Inc.
-
Merck
-
Verum Analytics LLC
-
Hamilton
-
Endress+Hauser Group Services AG
-
Viavi Solutions Inc.
-
Metrohm AG
-
Control Development Co., Ltd.
-
screw
-
Schmidt + Hensch
-
Sensum DOO
-
Ametech Co., Ltd.
-
Centronic Co., Ltd.
For more information on this report, please visit: https://www.researchandmarkets.com/r/vmo27d
About ResearchAndMarkets.com
ResearchAndMarkets.com is a leading global source of international market research reports and market data providing the latest information on international markets, regional markets, key industries, top companies, new products and latest trends.
Attachments
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
